1
Return

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

delete2026-08-10
delete0
delete
OA
AI
D
Dhir Gala
S
Sameer Rao *
M
Manas Gunani
K
Kajol Shah
A
Anand V. Kulkarni
K
Karn Wijarnpreecha
D
Daniel Q. Huang
P
Pojsakorn Danpanichkul
A
Ahmed Al‐Khazraji
K
Kaveh Hajifathalian
V
Vivek Lingiah
P
Paul J. Gaglio
N
Nikki Duong
C
Christine Gerula
DOI:10.1111/apt.70896delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Coronary artery disease (CAD) is common in cirrhosis patients because of shared risk factors, including metabolic syndrome and alcohol use; however, outcomes after percutaneous coronary intervention (PCI) remain poorly defined.
Keywords:
antiplatelet therapy
cirrhosis
coronary artery disease
percutaneous coronary intervention
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

A
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF:
6.7
Papers:
422
Citations:
0

Organization

R
rutgers new jersey medical school
Scholars:
96
Papers: 41
Citations: 1
S
stanford university
Scholars:
9.2K
Papers: 3.6K
Citations: 0
T
texas tech university health science center
Scholars:
13
Papers: 8
Citations: 0
A
Asian Institute of Gastroenterology
Scholars:
64
Papers: 25
Citations: 553
U
university of arizona college of medicine
Scholars:
25
Papers: 14
Citations: 0
A
allegheny health network
Scholars:
924
Papers: 440
Citations: 0
N
National University of Singapore
Scholars:
7.4W
Papers: 6.4W
Citations: 11.4W
Cited Papers

Cited Papers

Citing Papers

Citing Papers